Some of the biochemical alterations in FHH, including increased calcium and PTH, can stimulate FGF23 production, while Gα11 deficiency may impair skeletal FGF23 production (32, 33). The gene discussed is FGF23; the disease is familial hypocalciuric hypercalcemia.